Actavis to acquire Allergan for $66B

By BC Staff | Nov 18, 2014 | 3:24 AM GMT

Actavis plc (NYSE:ACT) will acquire Allergan Inc. (NYSE:AGN) for $66 billion, or $219 per share. The price represents a 10% premium to Allergan's closing price of